Scientific Sessions 2024  /  AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management: A JAMA Session  /  Regulatory landscape for AI-enabled digital biomarkers: how should we evaluate digital vs traditional biomarkers
Logo

American Heart Association

  2
  0

Final ID:

Regulatory landscape for AI-enabled digital biomarkers: how should we evaluate digital vs traditional biomarkers

  • Saha, Anindita  ( FDA , Washington DC , District of Columbia , United States )
  • Tarver, Michelle  ( FDA , Washington DC , District of Columbia , United States )
    • Author Disclosures:
    Anindita Saha: DO NOT have relevant financial relationships | Michelle Tarver: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

AI-enabled Digital Biomarkers for Enhancing Cardiovascular Disease Prediction and Management: A JAMA Session

Sunday, 11/17/2024 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Scalable AI-biomarkers for echocardiography to enable prediction, diagnosis, and prognostication

Oikonomou Evangelos, Sengupta Partho

AI-ECG as a global marker of cardiovascular risk: precision phenotyping across resource settings

Brant Luisa, Svennberg Emma

You have to be authorized to contact abstract author. Please, Login
Not Available